Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3056% below fair value
$12.19−0.35 (-2.79%)
Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%
Medifast total assets
Total assets on the balance sheet at the end of each period.
Medifast's total assets was $239.76M at Sep 30, 2026. For fiscal 2025 it was $247.97M, down 12.8% from the year before. Over ten years it grew 7.9% a year on average. The highest annual figure on record is $398.33M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.97M | -12.8% |
| FY2024 | Dec 31, 2024 | $284.21M | -8.3% |
| FY2023 | Dec 31, 2023 | $309.91M | -2.0% |
| FY2022 | Dec 31, 2022 | $316.21M | -20.6% |
| FY2021 | Dec 31, 2021 | $398.33M | +44.3% |
| FY2020 | Dec 31, 2020 | $276.08M | +41.8% |
| FY2019 | Dec 31, 2019 | $194.65M | +14.9% |
| FY2018 | Dec 31, 2018 | $169.43M | +16.1% |
| FY2017 | Dec 31, 2017 | $145.93M | +20.4% |
| FY2016 | Dec 31, 2016 | $121.22M | +4.4% |
| FY2015 | Dec 31, 2015 | $116.12M | +0.2% |
| FY2014 | Dec 31, 2014 | $115.91M | -12.6% |
| FY2013 | Dec 31, 2013 | $132.65M | +1.8% |
| FY2012 | Dec 31, 2012 | $130.25M | +23.3% |
| FY2011 | Dec 31, 2011 | $105.67M | +12.3% |
| FY2010 | Dec 31, 2010 | $94.06M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $239.76M | -10.6% |
| Q2 FY2026 | Jun 30, 2026 | $260.40M | -3.3% |
| Q1 FY2026 | Mar 31, 2026 | $252.05M | -10.0% |
| Q4 FY2025 | Dec 31, 2025 | $247.97M | -12.8% |
| Q3 FY2025 | Sep 30, 2025 | $268.21M | -7.9% |
| Q2 FY2025 | Jun 30, 2025 | $269.33M | -8.2% |
| Q1 FY2025 | Mar 31, 2025 | $280.01M | -7.5% |
| Q4 FY2024 | Dec 31, 2024 | $284.21M | -8.3% |
| Q3 FY2024 | Sep 30, 2024 | $291.24M | -9.0% |
| Q2 FY2024 | Jun 30, 2024 | $293.53M | -7.9% |
| Q1 FY2024 | Mar 31, 2024 | $302.76M | -5.9% |
| Q4 FY2023 | Dec 31, 2023 | $309.91M | -2.0% |
| Q3 FY2023 | Sep 30, 2023 | $320.02M | -1.9% |
| Q2 FY2023 | Jun 30, 2023 | $318.73M | -6.4% |
| Q1 FY2023 | Mar 31, 2023 | $321.61M | -23.7% |
| Q4 FY2022 | Dec 31, 2022 | $316.21M | -20.6% |
| Q3 FY2022 | Sep 30, 2022 | $326.35M | -12.1% |
| Q2 FY2022 | Jun 30, 2022 | $340.55M | -6.5% |
| Q1 FY2022 | Mar 31, 2022 | $421.44M | +29.1% |
| Q4 FY2021 | Dec 31, 2021 | $398.33M | +44.3% |
| Q3 FY2021 | Sep 30, 2021 | $371.37M | +42.4% |
| Q2 FY2021 | Jun 30, 2021 | $364.23M | +56.9% |
| Q1 FY2021 | Mar 31, 2021 | $326.40M | +61.5% |
| Q4 FY2020 | Dec 31, 2020 | $276.08M | +41.8% |
| Q3 FY2020 | Sep 30, 2020 | $260.79M | +31.3% |
| Q2 FY2020 | Jun 30, 2020 | $232.09M | +9.2% |
| Q1 FY2020 | Mar 31, 2020 | $202.14M | -3.8% |
| Q4 FY2019 | Dec 31, 2019 | $194.65M | +14.9% |
| Q3 FY2019 | Sep 30, 2019 | $198.59M | +13.8% |
| Q2 FY2019 | Jun 30, 2019 | $212.57M | +36.0% |
| Q1 FY2019 | Mar 31, 2019 | $210.07M | +38.4% |
| Q4 FY2018 | Dec 31, 2018 | $169.43M | +16.1% |
| Q3 FY2018 | Sep 30, 2018 | $174.45M | +29.7% |
| Q2 FY2018 | Jun 30, 2018 | $156.31M | +20.7% |
| Q1 FY2018 | Mar 31, 2018 | $151.82M | +23.5% |
| Q4 FY2017 | Dec 31, 2017 | $145.93M | +20.4% |
| Q3 FY2017 | Sep 30, 2017 | $134.46M | – |
| Q2 FY2017 | Jun 30, 2017 | $129.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $122.95M | – |
| Q4 FY2016 | Dec 31, 2016 | $121.22M | – |
See a number that looks wrong?